Home
>
National Drug Code (NDC)
>
Irbesartan and Hydrochlorothiazide
Irbesartan and Hydrochlorothiazide - 0591-2785-19 - (IRBESARTAN AND HYDROCHLOROTHIAZIDE)
Drug Information of Irbesartan and Hydrochlorothiazide
| Product NDC: | 0591-2785 |
| Proprietary Name: | Irbesartan and Hydrochlorothiazide |
| Non Proprietary Name: | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Active Ingredient(s): | 12.5; 150 mg/1; mg/1 & nbsp; IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Irbesartan and Hydrochlorothiazide
| Product NDC: | 0591-2785 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091539 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121022 |
Package Information of Irbesartan and Hydrochlorothiazide
| Package NDC: | 0591-2785-19 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-2785-19) |
NDC Information of Irbesartan and Hydrochlorothiazide
| NDC Code | 0591-2785-19 |
| Proprietary Name | Irbesartan and Hydrochlorothiazide |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-2785-19) |
| Product NDC | 0591-2785 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20121022 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | HYDROCHLOROTHIAZIDE; IRBESARTAN |
| Strength Number | 12.5; 150 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
